Abstract: Aspects of the disclosure relate to identifying and resolving consumer transactions using consumer call analytics. The computing platform may monitor consumer transactions and score each detected transaction. The computing platform may predict, using the score associated with the transaction, whether the consumer may request assistance with the transaction. The computing platform may receive, from the consumer, a request for assistance with at least one transaction. The computing platform may use a unique consumer identifier to identify transactions associated with the consumer. The computing platform may determine whether at least one similar consumer request for assistance was previously received. If at least one similar consumer request for assistance was previously received, the computing platform may retrieve the previously received request and a corresponding solution.

Abstract: Aspects of the disclosure relate to generating transaction recommendations based on monitoring and analyzing consumer transactions. The computing platform may monitor consumer transactions and a transaction history associated with a consumer. The computing platform may analyze the transaction history and identify transactional issues the consumer may have experienced. The computing platform may determine whether current enterprise organization programs address the identified transactional issues. If the current enterprise organization programs fail to address the transactional issues, the computing platform may generate solutions to the transactional issues. Alternatively, if the current enterprise organization programs address the transactional issues, the computing platform may retrieve the programs. The computing platform may initiate communication with the consumer to transmit the programs and/or the generated solutions.

Abstract: The present invention relates to the field of antibody fragments, which specifically binds an epitope of human and/or murine FAP and which may be linked to an entity such as a moiety. The antibody fragment and the compound formed may be used for therapy or diagnostic purposes.

Abstract: The present invention relates to the field of antibody fragments, which specifically binds an epitope of human folate receptor alpha (FOLR1) and which may be linked to an entity such as a moiety. The antibody fragment and the compound formed may be used for therapy or diagnostic purposes.